Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 393
Selected: 0
NCT IDTitle
NCT04348682Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging
NCT04305925Focal Laser Ablation of Prostate Cancer
NCT00024076Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
NCT02928510Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
NCT00910650Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
NCT05950113CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT03240861Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
NCT03319342Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors
NCT05319873Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
NCT03425461Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma
NCT06387173Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
NCT00005083Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT05775471Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
NCT05595499Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
NCT04069923OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects
NCT04290897Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors
NCT01532362Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer
NCT00052286Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
NCT04603365Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer
NCT01180907The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases
NCT00003143Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation
NCT04280471Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease
NCT00091299Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
NCT00045318Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction
NCT04765150Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
NCT04147494Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
NCT01059513Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer
NCT05256641Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
NCT00005996SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT00098462Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00023816Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma
NCT01204684Dendritic Cell Vaccine for Patients With Brain Tumors
NCT00066547Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy
NCT00005992Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005072Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer
NCT02336763Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases
NCT02879994Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer
NCT00020995Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer
NCT0288830118F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions
NCT00020787Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
NCT00685516Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery
NCT00039312Comparison of Screening Tests in Detecting Cervical Neoplasia
NCT00112775BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate
NCT00052273LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
NCT03953157Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors
NCT04459273Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
NCT00999557Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
NCT03409419PET Imaging of the Immune System Using Analog Probes
NCT00071968Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
NCT00004979Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors